Skip to main content

Cero Therapeutics Holdings, Inc.

CEROW
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001870404

No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $4 in total; no superinvestor holds it.

Other share classesCERO

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, 0 vs. previous quarter
1
13F valueReported value at the end of Q2 2026
$4
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding CEROW, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding CEROW at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Cero Therapeutics Holdings, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 13, 2024 (view filing)6:41 PM ETDec 11-132 daysYK Bioventures Opportunities GP I, LLC and 3 others10% OwnerSSale−5.96M$0.0672−$400.5K−31.4%13.0M after3 lots
Dec 10, 2024 (view filing)8:44 PM ETDec 6-104 daysYK Bioventures Opportunities GP I, LLC and 3 others10% OwnerSSale−3.66M$0.1048−$383.4K−16.2%19.0M after3 lots
Nov 20, 2024 (view filing)4:04 PM ETSep 2556 daysLateSloan Stuart M10% OwnerSSaleCommon Stock, $0.0001 par value per share−532.5K$0.1043−$55.5K−2.5%21.1M after
Nov 14, 2024 (view filing)8:14 PM ETOct 1035 daysLateYK Bioventures Opportunities GP I, LLC and 3 others10% OwnerSSale−3.25M$0.10−$325.0K−12.6%22.6M after

Top 10 13F holders, Q2 2026

The largest institutional positions in Cero Therapeutics Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 1 holders
Institutions holding CEROW in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Ancora Advisors, LLC2,500$40.00%00.0%Unchanged